首页> 外文期刊>Chemistry: A European journal >Synthesis of a novel pentagastrin-drug conjugate for a targeted tumor therapy
【24h】

Synthesis of a novel pentagastrin-drug conjugate for a targeted tumor therapy

机译:新型五肽胃泌素-药物偶联物的合成用于靶向肿瘤治疗

获取原文
获取原文并翻译 | 示例
           

摘要

The synthesis of the novel pentagastrin seco-CBI conjugate 3, which is based on the highly cytotoxic antitumor antibiotic (+)-duocarmycin SA (1), is reported. A key step in the synthesis is the palladium -catalyzed carbonylation of aryl bromide 7 to give the benzyl ester 16, which is transformed into the new seco-CBI derivative, 21 bearing a carboxylic acid ester moiety. Subsequent transformation of 21 into an activated ester followed by the introduction of beta-alanine and tetragastrin led to the new pentagastrin drug 3 that contains a peptide moiety for targeting cancer cells expressing CCK-B/gastrin receptors.
机译:报道了基于高度细胞毒性的抗肿瘤抗生素(+)-多卡霉素SA(1)的新型五肽胃泌素seco-CBI共轭物3的合成。合成中的关键步骤是钯催化的芳基溴化物7的羰基化反应,生成苄基酯16,该苄基酯16转化为新的seco-CBI衍生物21,带有羧酸酯部分。随后将21转化为活化的酯,然后引入β-丙氨酸和四胃泌素,导致产生新的五肽胃泌素药物3,该药物包含用于靶向表达CCK-B /胃泌素受体的癌细胞的肽部分。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号